Matches in Nanopublications for { ?s ?p "Ponatinib is a novel Bcr-Abl tyrosine kinase inhibitor that is especially effective against the T315I mutation for the treatment of chronic myeloid leukemia. FDA approved on December 14, 2012."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.